908 Devices Inc

We maintain a bullish medium-term bias in this speculative stock amid a Stage 2 advance; however, near-term execution is deferred due to overextension and overbought conditions at recent highs. We await a pullback into the rising short-term EMAs for a more asymmetric entry zone. The long-term uptrend remains intact, supported by sequential higher highs and lows and rising major moving averages.

• ↑Q1 '26 revenue +14% YoY to $13.4M; state/local ~50%
• ↑NearLab acquisition adds ~$2.5M revenue in 2026 and expands product line
• ↓Q1 2026 net loss widened to $12M from $9.8M a year ago